Altimmune (ALT) Preferred Dividend Payments (2016 - 2019)
Altimmune (ALT) posted quarterly Preferred Dividend Payments of $452925.0 for Q1 2019, down 76.05% year-over-year from $1.9 million in Q1 2018, and down 41.97% quarter-over-quarter from $780525.0 in Q4 2018.
Analysis
Altimmune (ALT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends
Altimmune (ALT) has reported Preferred Dividend Payments for 4 consecutive years, with $452925.0 the latest figure, recorded in Q1 2019.
- In Q1 2019, Preferred Dividend Payments fell 76.05% year-over-year to $452925.0; the TTM figure through Dec 2019 stood at $452925.0 (down 86.31% YoY), while the FY2019 annual figure was $452925.0, down 86.31% from the prior year.
- Preferred Dividend Payments retreated to $452925.0 in Q1 2019 per ALT's latest filing, from $780525.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.8 million in Q4 2017 and bottomed at -$64139.0 in Q3 2018.
- Historically, Preferred Dividend Payments has averaged $750282.7 across 4 years, with a median of $286955.5 in 2016.
- Annual changes were most pronounced in 2017 — Preferred Dividend Payments soared 2218.34% — and 2018, when it tumbled 103.27%.
- Altimmune's Preferred Dividend Payments stood at $120986.0 in 2016, then jumped by 2218.34% to $2.8 million in 2017, then slumped by 72.17% to $780525.0 in 2018, then plunged by 41.97% to $452925.0 in 2019.
- Business Quant data shows ALT's Preferred Dividend Payments at $452925.0 in Q1 2019, $780525.0 in Q4 2018, and -$64139.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Altimmune | 625.13 Mn | 625.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 452,925.00 |
| Dec 31, 2018 | 780,525.00 |
| Sep 30, 2018 | -64,139.00 |
| Jun 30, 2018 | 700,093.00 |
| Mar 31, 2018 | 1.89 Mn |
| Dec 31, 2017 | 2.80 Mn |
| Sep 30, 2017 | 1.96 Mn |
| Jun 30, 2017 | 44,713.00 |
| Mar 31, 2017 | 118,356.00 |
| Dec 31, 2016 | 120,986.00 |
| Sep 30, 2016 | 104,548.00 |
| Jun 30, 2016 | 87,123.00 |